Literature DB >> 32933999

Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges.

Erik Berg Schmidt1,2, Berit Storgaard Hedegaard2,3, Kjetil Retterstøl4,5.   

Abstract

Entities:  

Keywords:  clinical genetics; lipoproteins and hyperlipidaemia

Mesh：

Year:  2020        PMID： 32933999     DOI： 10.1136/heartjnl-2019-316276

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study.

Authors:  Chan Joo Lee; Sanghyun Park; Kyungdo Han; Sang-Hak Lee
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

2.  Familial hypercholesterolaemia: a study protocol for identification and investigation of potential causes and markers of subclinical coronary artery disease in the Faroe Islands.

Authors:  Sanna Á Borg; Michael Rene Skjelbo Nielsen; Peter Søgaard; Søren Lundbye-Christensen; Jan Jóanesarson; Tomas Zaremba; Rudi Kollslíð; Erik Berg Schmidt; Albert Marni Joensen; Christian Sørensen Bork
Journal:  BMJ Open       Date:  2022-04-12       Impact factor: 2.692

3.  Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway.

Authors:  Liv J Mundal; Jannicke Igland; Karianne Svendsen; Kirsten B Holven; Trond P Leren; Kjetil Retterstøl
Journal:  JAMA Netw Open       Date:  2022-04-01

Review 4.  2022 Consensus statement on the management of familial hypercholesterolemia in Korea.

Authors:  Chan Joo Lee; Minjae Yoon; Hyun-Jae Kang; Byung Jin Kim; Sung Hee Choi; In-Kyung Jeong; Sang-Hak Lee
Journal:  Korean J Intern Med       Date:  2022-07-27       Impact factor: 3.165

Review 5.  2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea.

Authors:  Chan Joo Lee; Minjae Yoon; Hyun-Jae Kang; Byung Jin Kim; Sung Hee Choi; In-Kyung Jeong; Sang-Hak Lee
Journal:  J Lipid Atheroscler       Date:  2022-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.